A body of the European Medicines Agency responsible for assessing the content of Pediatric Investigation Plans (PIPs; a mandatory supplement to all new marketing authorisation applications which sets out the effect of the new drug on the pediatric population); PDCO may either agree to the PIP or refuse it.
Menu